Monographie - Ipratropium bromide - Stabilis 4.0

Pēdējā atjaunošana :
19/11/2024

Muskarīnjūtīgo receptoru antagonisti

Ipratropium bromide

Aerosols

Stabilitāte farmaceitisko preparātu

Maisījuma stabilitāte

Stabilitāti ietekmējoši faktori

Saderība

Literatūras saraksts

pdf

Ķīmiskā uzbūve

Aerosols

Literatūras saraksts

Aerosols

Literatūras saraksts : Ipratropium bromide

	tips	publicēšana
665	Žurnāls	Blondino, FE, Baker M. Stability of Nebulizer Admixtures. Int J Pharm Compound 2005 ; 9, 4: 323-326.
2550	Žurnāls	Roberts GW, Rossi S.O.P. Compatibility of nebulizer solutions Aust J Hosp Pharm 1993 ; 23: 35-37.
2635	Žurnāls	Yamreudeewoh W, Teixeira G, Mayer GE. Stability of levalbuterol in a mixture of levalbuterol and ipratropium nebulizer solution. Hosp Pharm 2008 ; 43, 4: 303-306.
2685	Žurnāls	Jacobson GA, Peterson GM. Stability of ipratropium bromide and salbutamol nebuliser admixtures. Int J Pharm Pract 1995 ; 3: 169-173.
2770	Žurnāls	Krämer I, Schwabe A, Lichtinghagen R, Kamin W. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol. Pharmazie 2007 ; 62, 10: 760-766.
2774	Žurnāls	McKenzie J.E, Mario Cruz-Rivera M. Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions. Ann Pharmacotherapy 2004 ; 38: 967-972.
2787	Žurnāls	Lee TY, Chen CM, Lee CN, Chaing YC. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
2790	Žurnāls	Kamin W, Schwabe A, Krämer I. Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Int J COPD 2007 ; 1, 4: 599-607.
2803	Žurnāls	Bonasia PJ, McVicar WK, Williams B, Ong S. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium. Respiratory Care 2008 ; 683, 12: 1716-1722.
3019	Žurnāls	Bonasia P, Cook C, Cheng Y et al. Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. Curr Med Res Opin 2007 ; 23: 2477-2483.
3472	Žurnāls	Krämer I, Schwabe A, Kamin W. Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten. Krankenhauspharmazie 2007 ; 28, 5: 170-178.
3498	Žurnāls	Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.

Mentions Légales